Target intelligence / Profile preview

TMEM14B divergent transcript (TMEM14B-DT)

Target: TMEM14B-DT
Molecular classification: Other (long non-coding RNA, lncRNA)

Overview

TMEM14B-DT refers to a divergent (non-protein coding) transcript from the TMEM14B locus. It is annotated as a long non-coding RNA (lncRNA) and does not encode the TMEM14B protein. There is currently no evidence that TMEM14B-DT acts as a therapeutic target, receptor, enzyme, transporter, or other canonical drug target class. Information about its function, roles in disease, interacting drugs, or clinical use as a biomarker is either absent or not established[1][4].

Other names: TMEM14B-DTTMEM14B divergent transcript

Beyond the preview

Go deeper on TMEM14B divergent transcript (TMEM14B-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TMEM14B divergent transcript (TMEM14B-DT).

Explore the full profile